ARKG Holdings of ADPT
Adaptive Biotechnologies
Adaptive Biotechnologies Corporation focuses on using the adaptive immune system to transform the diagnosis and treatment of diseases. The company makes money by selling its immune-driven testing and data analytics platforms to healthcare providers, pharmaceutical companies, and researchers, enabling more precise disease diagnosis and personalized treatment approaches.
Trades of ADPT in ARKG
The ten most recent trades of Adaptive Biotechnologies in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 15, 2025 | Sell | $238,147 | 0.42% | 0.02% |
| Jan 14, 2025 | Sell | $32,687 | 0.06% | 0.00% |
| Jan 13, 2025 | Sell | $487,254 | 0.92% | 0.05% |
| Jan 10, 2025 | Sell | $837,056 | 1.54% | 0.07% |
| Jan 08, 2025 | Sell | $1,283,099 | 2.16% | 0.11% |
| Jan 07, 2025 | Sell | $969,444 | 1.56% | 0.08% |
| Jan 06, 2025 | Sell | $4,312,444 | 6.35% | 0.38% |
| Dec 31, 2024 | Sell | $106,621 | 0.19% | 0.01% |
| Dec 30, 2024 | Sell | $216,523 | 0.38% | 0.02% |
| Dec 27, 2024 | Sell | $20,609 | 0.03% | 0.00% |